These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34802023)

  • 1. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
    Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
    Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
    PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates
    Li Y; Yang Z; Ge Q; Zhang Y; Gao M; Liu X; Zhang L
    Infect Drug Resist; 2024; 17():3385-3393. PubMed ID: 39131518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
    J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
    Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.
    Chesov D; Lange C; Daduna F; Crudu V; Preyer R; Ernst M; Kalsdorf B
    PLoS One; 2015; 10(3):e0120006. PubMed ID: 25785445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of IFN-γ/IL-2 FluoroSpot assay for distinguishing active tuberculosis from non-active tuberculosis: A cohort study.
    Zhang L; Wan S; Ye S; Cheng X; Zhang Y; Shi X; Zhou B; Sun X; Liu X
    Clin Chim Acta; 2019 Dec; 499():64-69. PubMed ID: 31454491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Xue Y; Liu W; Song H; Huang Y; Tang G; Wang F; Wang Q; Cai Y; Sun Z
    BMC Infect Dis; 2022 Dec; 22(1):965. PubMed ID: 36581808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
    Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
    Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of
    Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X
    Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis.
    Devalraju KP; Neela VSK; Ramaseri SS; Chaudhury A; Van A; Krovvidi SS; Vankayalapati R; Valluri VL
    BMC Infect Dis; 2018 Jul; 18(1):321. PubMed ID: 29996789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review on Novel
    Meier NR; Jacobsen M; Ottenhoff THM; Ritz N
    Front Immunol; 2018; 9():2476. PubMed ID: 30473692
    [No Abstract]   [Full Text] [Related]  

  • 20. Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country.
    Dirix V; Collart P; Van Praet A; Hites M; Dauby N; Allard S; Racapé J; Singh M; Locht C; Mascart F; Corbière V
    Front Immunol; 2022; 13():842604. PubMed ID: 35359958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.